Functional assessment of human femoral arteries after cryopreservation.
An established method for the cryopreservation of human femoral arteries for subsequent transplantation as allografts has been studied with particular attention to preservation of smooth muscle and endothelium. Human femoral arteries (HFAs) were harvested from multi-organ donors. Two groups were established; a control group of unfrozen HFAs and a group of cryopreserved HFAs. Cryopreservation was performed using RPMI solution containing dimethyl sulfoxide and the rate of cooling was 1 degrees C/min to -40 degrees C and faster thereafter until -150 degrees C was reached. The contraction and relaxation responses of unfrozen and frozen/thawed arteries were assessed by measurement of the isometric force generated by the HFAs in an organ bath. After thawing (warming was at 15 degrees C/min) the maximal contractile response to noradrenaline was 43% of the response of unfrozen HFAs. The endothelium-independent response to sodium nitroprusside was not altered, whereas the endothelium-dependent relaxation response to acetylcholine was slightly altered. The cryopreservation method used provided limited preservation of the contractility of human femoral arteries, and good preservation of both endothelium-independent and endothelium-dependent relaxation responses.
Esther Rendal Vázquez
M
M
Cryobiology Unit, Complejo Hospitalario Juan Canalejo, La Coruña, Spain. esther_rendal@canalejo.org
Rodríguez Cabarcos
M
M
Fernández Mallo
R O
RO
Sánchez Ibáñez
J
J
Segura Iglesias
R
R
Bermúdez González
T
T
Matheu Capó
G
G
Filgueira Fernández
P
P
Pértega Díaz
S
S
Andión Núñez
C
C
D000109:Acetylcholine / Q000494:pharmacology; D015925:Cryopreservation / Q000379:methods*; D003451:Cryoprotective Agents; D004730:Endothelium, Vascular / Q000187:drug effects / Q000293:injuries / Q000503:physiopathology; D005263:Femoral Artery / Q000187:drug effects / Q000293:injuries / Q000503:physiopathology; D006801:Humans; D066298:In Vitro Techniques; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000293:injuries / Q000503:physiopathology; D009599:Nitroprusside / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D012996:Solutions; D014661:Vasoconstriction / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects
D003451:Cryoprotective Agents; D012996:Solutions; D009599:Nitroprusside; D000109:Acetylcholine; D009638:Norepinephrine